BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 32278771)

  • 1. Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.
    Schefler AC; Fuller D; Anand R; Fuller T; Moore C; Munoz J; Kim RS;
    Am J Ophthalmol; 2020 Aug; 216():165-173. PubMed ID: 32278771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data.
    Muston D; Korobelnik JF; Reason T; Hawkins N; Chatzitheofilou I; Ryan F; Kaiser PK
    BMC Ophthalmol; 2018 Dec; 18(1):340. PubMed ID: 30591022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
    Bressler SB; Ayala AR; Bressler NM; Melia M; Qin H; Ferris FL; Flaxel CJ; Friedman SM; Glassman AR; Jampol LM; Rauser ME;
    JAMA Ophthalmol; 2016 Mar; 134(3):278-85. PubMed ID: 26746868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
    Elman MJ; Ayala A; Bressler NM; Browning D; Flaxel CJ; Glassman AR; Jampol LM; Stone TW;
    Ophthalmology; 2015 Feb; 122(2):375-81. PubMed ID: 25439614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
    Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol.
    Kaya M; Kocak N; Ozturk T; Bolluk V; Ayhan Z; Kaynak S
    Eye (Lond); 2021 Mar; 35(3):777-785. PubMed ID: 32398852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy.
    Sepah YJ; Do DV; Mesquida M; Day BM; Blotner S; Afridi R; Halim MS; Hong K; Wakshull E; Fauser S; Stoilov I; Dong Nguyen Q; ;
    Eye (Lond); 2024 Jun; 38(9):1755-1761. PubMed ID: 38622330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different treatment regimens of ranibizumab 0.5 mg for neovascular age-related macular degeneration with or without polypoidal choroidal vasculopathy in Chinese patients: results from the Phase IV, randomized, DRAGON study.
    Li X; Zhu Q; Egger A; Chang L; Wolf S; Song Y; Zhang J; Dong F; Xu X; Weisberger A
    Acta Ophthalmol; 2021 May; 99(3):e336-e345. PubMed ID: 33377611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological Biomarkers Related to Visual Acuity in Patients With Radiation Retinopathy Treated With Intravitreal Ranibizumab.
    Corona ST; Ali OI; Yu HJ; Schefler AC;
    Ophthalmic Surg Lasers Imaging Retina; 2024 May; 55(5):255-262. PubMed ID: 38408221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
    Lin J; Chang JS; Yannuzzi NA; Smiddy WE
    Ophthalmology; 2018 Sep; 125(9):1393-1400. PubMed ID: 29606379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Ranibizumab for evaluating focal laser combination therapy for refractory diabetic macular edema patients: an exploratory study on the RELAND trials.
    Hatano M; Wakuta M; Yamamoto K; Arai E; Enoki M; Fujimoto K; Yamauchi K; Ishikawa K; Sonoda KH; Kimura K
    Sci Rep; 2023 Dec; 13(1):22965. PubMed ID: 38151499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Retina; 2019 Sep; 39(9):1646-1654. PubMed ID: 30807516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experience of ranibizumab therapy for neovascular age-related macular degeneration from Turkey.
    Cebeci Z; Yilmaz YC; Kir N
    Int J Ophthalmol; 2018; 11(2):267-273. PubMed ID: 29487818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment.
    Baker CW; Josic K; Maguire MG; Jampol LM; Martin DF; Rofagha S; Sun JK;
    Ophthalmology; 2023 May; 130(5):533-541. PubMed ID: 36521571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-vascular endothelial growth factor in the treatment of macular edema in epidemic retinitis.
    Kawali AA; Mohan A; Mehta R; Mahendradas P; Srinivasan S; Shetty B
    Indian J Ophthalmol; 2020 Sep; 68(9):1912-1915. PubMed ID: 32823413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central subfield thickness predicts visual acuity outcomes in plaque-irradiated eyes with choroidal melanoma.
    Shah SM; Tanke LB; Deufel CL; Petersen IA; Corbin KS; Hodge DO; Olsen TW; Dalvin LA
    Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1305-1320. PubMed ID: 37950755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes.
    Salabati M; Huang C; Kamalipour A; Yu HJ; Mahmoudzadeh R; Jeng-Miller K; Chen E; Shah CP; Wykoff CC; Hsu J
    Ophthalmol Sci; 2024; 4(2):100372. PubMed ID: 37868803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent and Poor-Responsive Cystoid Macular Edema after Stereotactic Radiotherapy in Neovascular Age-Related Macular Degeneration: A Case Report of Three Patients.
    Billia F; Hatz-Wurziger K
    Klin Monbl Augenheilkd; 2024 Apr; 241(4):459-462. PubMed ID: 38653276
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options.
    Mularska W; Chicheł A; Rospond-Kubiak I
    J Contemp Brachytherapy; 2023 Oct; 15(5):372-382. PubMed ID: 38026080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular shunt in radiation retinopathy.
    Carreira P; Ferreira M; Brízido M; Cabral D
    Am J Ophthalmol Case Rep; 2024 Jun; 34():102019. PubMed ID: 38433978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.